Literature DB >> 7410345

Monoclonal antibody covalently coupled with fatty acid. A reagent for in vitro liposome targeting.

A Huang, L Huang, S J Kennel.   

Abstract

Monoclonal antibody to the mouse histocompatibility antigen, H-2k, was derivatized with palmitic acid using an activated ester of N-hydroxysuccinimide. About 70% of the resulting amphipathic antibody could be incorporated into liposomes by a detergent-dialysis method. The antibody-bound liposomes were about 900 A in diameter and were heterogeneous in terms of the number of antibody molecules per liposome. These liposomes showed specific binding affinity to mouse L-929 cells (H-2k), but not to A-31 cells (H-2d), whereas native liposomes showed no detectable binding to either cell type. The specific binding of anti-H-2k-bound liposomes to L-929 cells could be blocked by a preincubation of cells with an excess of free, underivatized anti-H-2k antibody but not by normal mouse IgG. Using a fluorescent phospholipid, liposomes containing anti-H-2k specifically labeled L-929 cells but not A-31 cells in a mixed culture. Liposomes containing normal mouse IgG did not significantly label either cell type. These results clearly demonstrated the effectiveness of the monoclonal antibody for liposome targeting.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7410345

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Phototoxic liposomes coupled to an antibody that alone cannot modulate its cell-surface antigen kill selected target cells.

Authors:  S Yemul; C Berger; M Katz; A Estabrook; R Edelson; H Bayley
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 2.  Immunoglobulins as targeting agents for liposome encapsulated drugs.

Authors:  P A Toonen; D J Crommelin
Journal:  Pharm Weekbl Sci       Date:  1983-12-16

3.  Use of monoclonal antibodies and liposomes to improve drug delivery. Present status and future implications.

Authors:  G Gregoriadis
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

4.  Inflammatory roles of P-selectin.

Authors:  D E Lorant; M K Topham; R E Whatley; R P McEver; T M McIntyre; S M Prescott; G A Zimmerman
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

5.  Targeting mesenchymal stem cells to activated endothelial cells.

Authors:  In Kap Ko; Thomas J Kean; James E Dennis
Journal:  Biomaterials       Date:  2009-04-17       Impact factor: 12.479

6.  Interaction of antibody-bearing small unilamellar liposomes with antigen-coated cells. The effect of antibody and antigen concentration on the liposomal and cell surface respectively.

Authors:  G Gregoriadis; A Meehan
Journal:  Biochem J       Date:  1981-11-15       Impact factor: 3.857

7.  Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo.

Authors:  D Aragnol; L D Leserman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

8.  Interaction of antibody-bearing small unilamellar liposomes with target free antigen in vitro and in vivo. Some influencing factors.

Authors:  G Gregoriadis; A Meehan; M M Mah
Journal:  Biochem J       Date:  1981-11-15       Impact factor: 3.857

9.  Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes.

Authors:  J Connor; L Huang
Journal:  J Cell Biol       Date:  1985-08       Impact factor: 10.539

10.  Cancer vaccine development: designing tumor cells for greater immunogenicity.

Authors:  Erica N Bozeman; Rangaiah Shashidharamurthy; Simon A Paulos; Ravi Palaniappan; Martin D'Souza; Periasamy Selvaraj
Journal:  Front Biosci (Landmark Ed)       Date:  2010-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.